| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.095 | 0.04 |